28th Feb 2006 07:05
Advanced Medical Solutions Grp PLC28 February 2006 For Immediate Release 28 February 2006 Advanced Medical Solutions Group plc ("AMS" or "the Company") LiquiBandTM approval in China progressing well Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalwoundcare technology company, today announces that it is making good progress ingetting approval to export its wound closure products into China. China has beenidentified as a major market opportunity for the Company's technology and itsproducts for wound closure and scar therapy. It is estimated that there arearound 7 million surgical operations performed per year in large and mediumsized hospitals in China with the vast majority of surgical incisions beingclosed using sutures. The first product undergoing registration is LiquiBandTMtissue adhesive. LiquiBandTM tissue adhesive is a medical grade superglue that is used as analternative to sutures and has been shown to offer benefits with regard toinfection control and in minimising scarring after surgery. AMS is a leader inthe use of tissue adhesives for closing wounds in Europe and is currentlyobtaining regulatory approval for these products in the US and Japan. All the various documents that have been requested have been compiled,translated and authenticated by the Chinese Embassy and are currently underreview by the Medical Devices bureau of the State Drug Administration. We areexpecting to receive the necessary approvals to allow us to enter this newmarket in 2007. Commenting on this announcement Dr. Don Evans, Chief Executive of AMS, stated: "I am pleased at the progress we are making with our product registration effortsin China. China is recognised as one of the fastest growing economies in theworld and presents a further exciting market opportunity for the Company'stissue adhesives." For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508 Don Evans, Chief Executive Mary Tavener, Finance Director www.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000 Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $13 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions isfocused on the design, development and manufacture of innovative andtechnologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS' resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing wounds sold direct to hospitals or through distributors. AMS' technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group